This effect of HT is likely to promote PPAR-α activation increasing the FA oxidation capacity of the liver with concomitant SREBP-1c downregulation reducing de novo lipogenesis [43], thus in agreement with the 42% reduction found in HFD-induced steatosis score that correlated with the decreases in the fat and TG contents. This evidence concerns the gene SREBF1 and steatosis.